Journal of Cardiovascular Pharmacology,
Journal Year:
2023,
Volume and Issue:
82(5), P. 345 - 346
Published: Sept. 1, 2023
The
development
and
clinical
application
of
statins
has
been
one
the
most
significant
advances
in
health
care
over
past
quarter
a
century.
Statins
have
shown
to
prevent
heart
failure
(HF),
reduce
risk
myocardial
infarction
stroke,
as
well
mortality
patients
with
without
coronary
artery
disease,
independent
serum
cholesterol.1
Their
role
established
HF
is,
however,
controversial.
Although
their
use
is
supported
by
observational
studies
meta-analyses,2,3
not
results
pivotal
large-scale
prospective
randomized
trials
reduced
ejection
fraction
(HFrEF),
GISSI-HF
(Gruppo
Italiano
per
la
Sperimentazione
della
Streptochinasi
nell'Infarto
Miocardico—Heart
Failure),
Controlled
Rosuvastatin
Multinational
Trial
(CORONA).4,5
There
suggestion
from
CORONA
trial
other
that
mild
evidenced
relatively
low
level
NT-pro
BNP
may
benefit.6
Current
guidelines
do
therefore
recommend
statin
indications
such
hypercholesterolemia,
diabetes,
or
atherosclerotic
cardiovascular
disease.7
data
suggest
can
be
continued
who
are
already
on
treatment.7
Given
large
number
proven
benefit
they
an
increasing
HF,
both
those
HFrEF
preserved
currently
being
treated
statin.
Thus,
it
important
understand
whether
these
will
at
increased
explanation
why
clear
beneficial
effect
hypercholesterolemia
and/or
disease
although
clearly
proven,
remains
uncertain.
In
this
issue
journal,
Ahmad
et
al8
compared
physical
performance
172
diagnosed
chronic
(50
122
statin)
59
control
patients.
They
measured
handgrip
strength,
gait
speed,
short
battery
plasma
biomarkers
including
sarcopenia
marker
C-terminal
agrin
fragment
−22
(CAF22),
intestinal
barrier
integrity
zonulin,
C-reactive
protein
(CRP)
correlated
markers
performance.
Not
surprisingly,
found
had
reduction
HF.
Of
interest
was
finding
irrespective
etiology,
elevation
CAF22
zonulin
there
strong
inverse
correlation
between
also
CAF22,
CRP
were
each
other.
However,
increase
receiving
worse
than
adversely
affect
neuromuscular
junction
permeability
resultant
systemic
inflammation.
some
but
all
previous
animals.9,10Thus,
reason
consider
implications
findings
apply
them
clinically
yet.
Increasing
evidence
suggests
(gut–heart
gut–brain
axis).11,12
An
suggested
diagnostic
dysfunction,
associated
lipoprotein
polysaccharide,
trimethylamine-N-oxide
decrease
short-chain
fatty
acids
butyrate.11,12
polysaccharide
acid
adverse
effects
inflammation;
renal
fibrosis;
platelet
activation
thrombosis;
major
depression;
cognitive
dysfunction
Alzheimer's
disease.11,12
study
implications,
should
pointed
out
observational,
small
(n
=
172),
even
smaller
50),
sodium
glucose
transport
inhibitor
mineralocorticoid
receptor
antagonist,
which
alter
microbiome
part
recommended
"4-pillar"
therapy
need
for
further
adequately
powered,
placebo-controlled
confirm
findings.
It
considerable
variation
ethnicity,
gender,
age,
diet.
Animal
statin.11,12
preclinical
studies,9,10
outcomes
HF1
benefits
outweigh
risks.
especially
advanced
inflammation
statin,11,12
possible
risks
benefits.
confirmed
prospective,
and,
if
confirmed,
evaluating
means
lowering
cholesterol
bypass
gut
PCSK9
inhibitors13
determine
similar
mechanisms
inducing
skeletal
muscle
mitochondrial
dysfunction.
effective
tolerated
numbers
inexpensive.
Before
advocating
change
we
only
implied
biomarker
findings,
thrombosis,
several
signaling
pathways.
Future
research
required
differences
lipophilic
versus
hydrophilic
outcomes,
rather
before
practice.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(16), P. 3647 - 3647
Published: Aug. 20, 2023
The
first
1000
days
after
birth
represent
a
critical
window
for
gut
microbiome
development,
which
is
essential
immune
system
maturation
and
overall
health.
undergoes
major
changes
during
this
period
due
to
shifts
in
diet
environment.
Disruptions
the
microbiota
early
life
can
have
lasting
health
effects,
including
increased
risks
of
inflammatory
disorders,
autoimmune
diseases,
neurological
obesity.
Maternal
environmental
factors
pregnancy
infancy
shape
infant
microbiota.
In
article,
we
will
review
how
maintaining
healthy
important
long-term
Furthermore,
briefly
include
fungal
colonization
its
effects
on
host
function,
are
discussed
as
part
ecosystem.
Additionally,
describe
potential
approaches
such
hydrogels
enriched
with
prebiotics
probiotics,
transplantation
(GMT)
pregnancy,
age-specific
microbial
ecosystem
therapeutics,
CRISPR
therapies
targeting
hold
advancing
research
development.
Nevertheless,
thorough
evaluation
their
safety,
effectiveness,
impacts
crucial
prior
application
clinical
approach.
article
emphasizes
need
continued
optimize
development
through
targeted
early-life
interventions.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(3), P. 645 - 645
Published: March 14, 2024
The
gut
microbiota
is
emerging
as
an
important
contributor
to
the
homeostasis
of
human
body
through
its
involvement
in
nutrition
and
metabolism,
protection
against
pathogens,
development
modulation
immune
system.
It
has
therefore
become
research
topic
recent
decades.
Although
association
between
intestinal
dysbiosis
numerous
digestive
pathologies
been
thoroughly
researched,
pancreatic
diseases
constitutes
a
novelty
specialized
literature.
In
years,
growing
evidence
pointed
critical
pancreas
regulating
microbiota,
well
impact
on
physiology,
which
implies
existence
bidirectional
connection
known
"gut-pancreas
axis".
theorized
that
any
change
at
either
these
levels
triggers
response
other
component,
hence
leading
evolution
pancreatitis.
However,
there
are
not
enough
data
determine
whether
underlying
cause
or
result
pancreatitis;
therefore,
more
needed
this
area.
purpose
narrative
review
highlight
role
pathogenesis
acute
chronic
pancreatitis,
evolution,
prospect
employing
therapeutic
intervention
for
Biomedicines,
Journal Year:
2023,
Volume and Issue:
11(9), P. 2480 - 2480
Published: Sept. 7, 2023
The
gut
microbiota
(GM)
plays
a
vital
role
in
human
health,
with
increasing
evidence
linking
its
imbalance
to
chronic
kidney
disease
and
end-stage
disease.
Although
the
exact
methods
underlying
kidney-GM
crosstalk
are
not
fully
understood,
interventions
targeting
GM
were
made
lay
three
aspects:
diagnostic,
predictive,
therapeutic
interventions.
While
these
show
promising
results
reducing
uremic
toxins
inflammation,
challenges
remain
form
of
patient-specific
variability,
potential
side
effects,
safety
concerns.
Our
understanding
GMs
is
still
evolving,
necessitating
further
research
elucidate
causal
relationship
mechanistic
interactions.
Personalized
focusing
on
specific
signatures
could
enhance
patient
outcomes.
However,
comprehensive
clinical
trials
needed
validate
approaches’
safety,
efficacy,
feasibility.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(16), P. 3609 - 3609
Published: Aug. 17, 2023
The
human
intestinal
microbiota
is
a
highly
intricate
structure
with
crucial
role
in
promoting
health
and
preventing
disease.
It
consists
of
diverse
microbial
communities
that
inhabit
the
gut
contribute
to
essential
functions
such
as
food
digestion,
nutrient
synthesis,
immune
system
development.
composition
function
are
influenced
by
variety
factors,
including
diet,
host
genetics,
environmental
features.
In
pediatric
patients,
particularly
dynamic
vulnerable
disruption
from
endogenous
exogenous
factors.
Recent
research
has
focused
on
understanding
interaction
between
kidneys.
individuals
chronic
kidney
disease,
there
often
significant
disturbance
microbiota.
This
imbalance
can
be
attributed
factors
like
increased
levels
harmful
toxins
entering
bloodstream,
inflammation,
oxidative
stress.
review
looks
at
what
known
about
link
child’s
gut–kidney
axis,
how
dysbiosis,
or
an
microbiome,
affects
treatments,
both
pharmaceutical
non-pharmaceutical,
available
for
this
condition.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(14), P. 3278 - 3278
Published: July 24, 2023
Considered
to
be
of
greater
complexity
than
the
human
genome
itself,
microbiome,
structure
body
made
up
trillions
bacteria,
viruses,
and
fungi,
has
proven
play
a
crucial
role
in
context
development
pathological
processes
body,
starting
from
various
infections,
autoimmune
diseases,
atopies,
culminating
its
involvement
some
forms
cancer,
diagnosis
that
is
considered
most
disabling
for
patient
psychological
point
view.
Therefore,
being
cornerstone
understanding
optimal
treatment
multitude
ailments,
body’s
microbiome
become
an
intensively
studied
subject
scientific
literature
last
decade.
This
review
aims
bring
microbiome–asthma
correlation
date
by
classifying
asthmatic
patterns,
emphasizing
patterns
perinatal
period
impact
pulmonary
dysbiosis
on
symptoms
children.
Likewise,
effects
intestinal
reflected
at
level
homeostasis
internal
environment
through
intestine–lung/vital
organs
axis,
circumstances
which
it
occurs,
but
also
main
methods
studying
bacterial
variability
used
diagnostic
purposes
research
should
not
omitted.
In
conclusion,
we
draw
current
future
therapeutic
lines
worthy
consideration
both
obtaining
maintaining
remission,
as
well
delaying
primary
acute
episodes
preventing
relapses.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: April 23, 2024
Being
defined
as
an
autoimmune,
chronic
pathology,
frequently
encountered
in
any
age
group,
but
especially
pediatrics,
celiac
disease
(also
called
gluten
enteropathy),
is
gaining
more
and
ground
terms
of
diagnosis,
also
interest
research.
The
data
from
the
literature
last
decades
attest
chameleonic
way
its
presentation,
there
may
be
both
classic
onset
symptoms
atypical
symptoms.
Given
impact
played
by
disease,
optimal
growth
development
children,
current
narrative
review
aims
to
highlight
presentation
methods,
intended
guide
clinician
towards
inclusion
pathology
differential
diagnosis
scheme.
To
these
we
add
summary
general
therapeutic
lines
regarding
underlying
condition
existing
comorbidities.
In
order
place
related
information
up
date,
performed
a
recent
articles
published
international
databases.
We
bring
forward
theories
approaches
manifestations.
Among
note
mainly
constitutional,
skin
or
mucous,
bone,
neuro-psychic,
renal,
reproductive
injuries,
disorders
biological
constants
association
with
multiple
autoimmunities.
Knowing
correlating
them
key
management
patients,
thus
reducing
subsequent
burden
disease.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Aug. 8, 2024
Despite
the
early
recognition
of
obesity
as
an
epidemic
with
global
implications,
research
on
its
pathogenesis
and
therapeutic
approach
is
still
rise.
The
literature
21st
century
records
excess
weight
found
in
up
to
1/3
children.
Both
determining
factors
systemic
effects
are
multiple
variable.
Regarding
involvement
potentiation
cardio-vascular,
pulmonary,
digestive,
metabolic,
neuro-psychic
or
even
dermatological
diseases,
information
already
broadly
outlined.
connection
between
underlying
disease
associated
comorbidities
seems
be
partially
attributable
oxidative
stress.
In
addition
these,
light
recent
COVID-19
pandemic,
role
played
by
stress
induction,
maintenance
chronic
inflammation
among
overweight
children
adolescents
becomes
a
topic
interest
again.
Thus,
this
review’s
purpose
update
general
data
obesity,
emphasis
physiopathological
mechanisms
that
underlie
it
involve
At
same
time,
we
briefly
present
latest
principles
pathology
diagnosis
management.
Among
will
mainly
emphasize
impact
endogenous
exogenous
antioxidants
evolutionary
course
pediatric
obesity.
order
achieve
our
objectives,
refer
most
studies
published
specialized
literature.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: April 23, 2024
Having
increased
popularity
during
the
Covid-19
pandemic,
vitamin
D3
is
currently
impressing
thanks
to
numerous
researches
aimed
at
its
interactions
with
body’s
homeostasis.
At
same
time,
there
a
peak
in
terms
of
recommendations
for
supplementation
it.
Some
studies
focus
on
link
between
autoimmune
diseases
and
nutritional
deficiencies,
especially
D3.
Since
specialized
literature
children
(patients
0-18
years
old)
far
from
equal
informational
diversity
adult-centered
branch,
this
review
aims
bring
up
date
relationship
microbial
balance
activity
pediatric
systemic
lupus
erythematosus
(pSLE).
The
desired
practical
purpose
resides
better
understanding
an
adequate,
individualized
management
affected
persons
reduce
morbidity.
center
summary
establish
impact
hypovitaminosis
D
development
evolution
erythematosus.
We
will
address
aspects
related
two
entities
played
by
pathophysiological
cascade
lupus,
but
also
risk
toxicity
effects
when
deficiency
over
supplemented
(hypervitaminosis
D).
debate
modulation
immune
function,
potentiation
inflammatory
processes,
increase
oxidative
stress,
perfusion
cognitive
brain
areas,
seasonal
incidence
SLE
severity.
Finally,
we
current
knowledge,
post-pandemic,
regarding
–
pSLE
relationship.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(15), P. 3359 - 3359
Published: July 28, 2023
Numerous
interrelationships
are
known
in
the
literature
that
have
final
effect
of
unmasking
or
influencing
various
pathologies.
Among
these,
present
article
aims
to
discuss
connection
between
systemic
lupus
erythematosus
(SLE)
and
human
microbiome.
The
main
purpose
this
work
is
popularize
information
about
impact
dysbiosis
on
pathogenesis
evolutionary
course
pediatric
patients
with
SLE.
Added
interest
knowledge
awareness
adjunctive
therapeutic
means
has
ultimate
goal
increasing
quality
life.
by
which
can
be
achieved
briefly
divided
into
prophylactic
curative,
depending
phase
condition
patient
is.
We
thus
reiterate
importance
clinician
acquiring
an
overview
SLE
microbiome,
doubled
in-depth
physio-pathogenic
interactions
two
(in
part
through
much-studied
gut-target
organ
axes—brain,
heart,
lung,
skin),
target
objective
being
obtaining
individualized,
multimodal
efficient
management
for
each
individual
patient.
Journal of Functional Foods,
Journal Year:
2024,
Volume and Issue:
115, P. 106108 - 106108
Published: March 5, 2024
Metabolic
syndrome
(MS),
which
involves
visceral
obesity,
hyperglycemia,
hypertension,
and
dyslipidemia,
has
become
a
global
health
challenge.
Preventive
measures
include
lifestyle
changes,
dietary
treatments,
etc.
Konjac
been
widely
used
as
culinary
ingredient
traditional
Chinese
medicine
in
Asian
countries
for
thousands
of
years.
The
main
component
the
konjac
tuber
is
glucomannan
(KGM),
kind
hydrocolloid
fiber.
Many
problems
diseases
are
affected
by
gut
microbiota,
may
provide
an
alternative
preventing
disease.
In
this
review,
we
describe
prevention
treatment
MS
using
KGM,
with
focus
on
its
impact
relation
to
regulation
microbes.
Developing
comprehensive
understanding
role
played
KGM
via
microbiota
will
help
us
determine
underlying
mechanisms
associated
microbiota.